Alira Health

Alira Health

Regulatory: MedTech

FDA U.S. Agent for Non-U.S. Companies

Providing guidance and expertise as liaisons

As a global company headquartered in the U.S., we understand the challenges of working with FDA regulatory as a non-U.S. organization. Our team of U.S.-based project managers have years of experience working with the FDA, and regularly guide our clients through the process as an FDA liaison.

Our liaisons serve in active negotiation with regulatory bodies, providing expertise and guidance for our clients on:
  • FDA establishment registration and device listing
  • FDA U.S. agent for foreign establishments
  • EU authorized representative

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • Innovation support, optimizing product development success every step of the way
  • Integrated and collaborative teams experience
  • Lifecycle approach

Related news

Events July 18, 2024
UXN Health 2024
Look for patient engagement expert Eduardo Perez onsite in Aarhus to connect on topics like integrating patient voices in solution design.
Co-Design MedTech Patient Engagement Pharma
News June 18, 2024
Alira Health Partners with Scottsdale Research Institute for Psilocybin Clinical Trials Funded by the State of Arizona
Alira Health, a global advisory and clinical research firm, announced today its collaboration with the Scottsdale Research Institute (SRI) to provide comprehensive regulatory and clinical(...)
Clinical Trials Regulatory
Reports May 20, 2024
Innovative Payment Schemes for Medtech in England, Germany, and France
This overview offers high-level details on the innovative payment schemes in England, Germany, and France.
MedTech
Case Studies May 14, 2024
Medtech Company Creates an Early Go-to-Market Strategy for Its Breakthrough IVD Solution
The client needed an early go-to-market strategy for their IVD solution to prepare for product development and launch in key European countries and the US.
IVDR Medical Devices MedTech
Case Studies May 8, 2024
Mid-Size Medtech Company with a Borderline Product Defines Strategy for EU Launch
Medtech company sought support in developing a regulatory strategy for the EU launch of their product with an aggressive timeline to launch.
Medical Devices MedTech Regulatory
Reports May 8, 2024
Value-Based Procurement in Australia
This white paper discusses why value-based healthcare and procurement are solutions in a robust healthcare system and identifies the medical technology sector as a collaborative partner(...)
MedTech Value-Based Contracts
Case Studies April 30, 2024
Medtech Company Leverages Bayesian Clinical Trial Design to Address FDA Feedback
A global medtech company needed help to address FDA feedback on their implant design that included a comparator and clearly demonstrated the safety and performance of this new device.
Clinical Trials Complex Innovative Design MedTech
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.